期刊文献+

PTEN基因与肿瘤抑制蛋白p53在子宫内膜癌组织中的表达及临床意义 被引量:7

Expression and clinical significance of PTEN gene and tumor suppressor protein p53 in endometrial cancer tissue
下载PDF
导出
摘要 目的探讨PTEN基因与肿瘤抑制蛋白p53在子宫内膜癌组织中的表达及其临床意义。方法 选取本院2013年7月-2015年6月的52例子宫内膜癌组织作为观察组,选取55例正常子宫内膜组织作为对照组,采用免疫组织化学技术检测两组的PTEN基因以及肿瘤抑制蛋白p53表达情况,并分析其与不同国际妇产科联盟(FIGO)分期、细胞分化程度及有无淋巴结转移的关系。结果 观察组的PTEN基因阳性表达率显著低于对照组,肿瘤抑制蛋白p53的阳性表达率显著高于对照组,差异有统计学意义(P〈0.05)。PTEN基因的表达与FIGO分期、细胞分化程度及淋巴结转移有关(P〈0.05)。肿瘤抑制蛋白p53的表达与FIGO分期及淋巴结转移有关(P〈0.05)。结论 PTEN基因与肿瘤抑制蛋白p53在子宫内膜癌组织中的表达异常,其在肿瘤的发生、发展过程中起着重要作用。 Objective To explore the expression and clinical significance of PTEN gene and tumor suppressor protein p53 in endometrial carcinoma tissue. Methods 52 cases of endometrial cancer tissue from July 2013 to June 2015 were selected as the observation group,55 cases of normal endometrial tissue were selected as the control group.The expression condition of PTEN gene and tumor suppressor protein p53 in the two groups were detected by immunohistochemical technique.The relationship between them and the FIGO staging,differentiation degree and lymph node metastasis were analyzed. Results The positive expression rate of PTEN gene in the observation group was lower than that in the control group,the positive expression rate of tumor suppressor protein p53 in the observation gruoup was higher than that in the control group,with significant difference (P〈0.05).The expression of PTEN gene was related to FIGO stage,differentiation degree and lymph node metastasis (P〈0.05).The expression of tumor suppressor protein p53 was related to FIGO stage and lymph node metastasis (P〈0.05). Conclusion The expression of PTEN gene and tumor suppressor protein p53 in endometrial carcinoma is abnormal,which plays an important role in the occurrence and development of cancer.
作者 刘丙营
出处 《中国当代医药》 2016年第8期58-60,共3页 China Modern Medicine
关键词 PTEN基因 肿瘤抑制蛋白p53 子宫内膜癌 表达 临床意义 PTEN gene Tumor suppressor protein p53 Endometrial cancer Expression Clinical significance
  • 相关文献

参考文献18

二级参考文献148

  • 1张育军,魏丽惠,王建六.肿瘤抑癌蛋白PTEN、P53在子宫内膜癌组织中的表达[J].中国妇产科临床杂志,2001,2(4):230-233. 被引量:11
  • 2刘淼,魏敏杰,赵福杰.HER-2/neu基因沉默对子宫内膜癌细胞株Ishikawa细胞增殖及其对孕激素敏感性的影响[J].沈阳药科大学学报,2008,25(S1):64-64. 被引量:2
  • 3高宝辉,谢丽微,祁旦巳,赵志光.子宫内膜样腺癌组织中p53蛋白和VEGF的表达及意义[J].临床与实验病理学杂志,2005,21(2):240-241. 被引量:7
  • 4丰有吉,陈晓军.妇科恶性肿瘤临床与基础研究进展[J].中国癌症杂志,2006,16(11):881-885. 被引量:7
  • 5Nagass S, Yamakama H, Sato S, et al. Identufieaion of a 790 kilobase of common allelic loss in chromosome.10,25 - 26 in human edomatrial cance [J]. Cancer Rea, 1997,57 : 1639 - 1633.
  • 6Mutter GL, lnce TA, Baak JP, et al. Molecular identification of latent precancers in histologically normal endometrium [ J ]. Cancer Res, 2001,61 : 4311 -4314.
  • 7LAX S F, KENDALL B, TASHIRO H, et al. The trequency of p53, Kras mutations, and microsatel/ite instabiliey differs in utenine endonetroid and serous carcinoma. Evidence of diseinct molecdlar genetic pathwas[J]. Cancer, 2000, 88:814-824.
  • 8KONG D, SUZUKIA, ZOU T, et al. PTEN is frequetly in primary endometrial carcinomas[ J]. Nat Gent, 1997, 17 : 143 - 144.
  • 9TASHIRO H, BLAZES MS, WU R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rate in other common gynecoloqic malignancies[ J]. Cancer Res, 1977, 57:3 935 -3 940.
  • 10Trope CG, Alektiar KM, Sabbatini PJ. Corpus Uteri: Epithelial tumours. In Principles and practice of gynecologic oncology. Hoskins WJ, Young RC, Markman M, Perez CA, Barakat R, Randall M (eds) 4th edn, Lippincott, Williams Wilkins: USA. 2005: 823-872.

共引文献74

同被引文献85

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部